PO.1.12 Transcriptome profiling and autoimmunity-related serological markers identify TP53 and C3aR as drug targets in neuropsychiatric systemic lupus erythematosus

Similar Items

• O15 B cell, T cell, cytotoxic/NK cell, and mitochondrial gene dysregulation patterns separate neuropsychiatric systemic lupus erythematosus patients into two distinct subgroups with differential anticipated response to targeted therapies
  by: Lorenzo Beretta, et al.
  Published: (2024-03-01)
• O23 Interferon upregulation and B and plasma cell gene dysregulation patterns reveal three distinct lupus nephritis subgroups with differential anticipated response to targeted therapies
  by: Lorenzo Beretta, et al.
  Published: (2024-03-01)
• Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last Decade
  by: Julius Lindblom, et al.
  Published: (2022-01-01)
• O28 Unveiling the impact of neuropsychiatric involvement in systemic lupus erythematosus on damage accrual
  by: Ioannis Parodis, et al.
  Published: (2024-03-01)
• P110 Impact of neuropsychiatric involvement on health-related quality of life in patients with systemic lupus erythematosus
  by: Ioannis Parodis, et al.
  Published: (2024-03-01)